Zimbabwe says the coronavirus variant first discovered in neighbouring South Africa now makes up more than 60% of cases within its borders.

It is the first country outside of South Africa to report that the so-called "501.YV2" variant is the dominant strain.

Botswana, Zambia, Ghana and the Gambia have also found some cases.

The announcement by Zimbabwe's government comes a day after a national lockdown was extended by two weeks.

Monday saw the delivery of 200,000 Sinopharm vaccine doses donated by China, with rollout set to begin on Thursday.

Air Zimbabwe Boeing 767- 200 ER carrying the Sinopharm #COVID19Vaccine consignment for Zimbabwe arrives at RGM International Airport. pic.twitter.com/KLhqk9N6gK

— Ministry of HealthZW (@MoHCCZim) February 15, 2021

Little data has been produced so far to prove how well China's vaccines combat the coronavirus variant first found in South Africa.

As reported by Reuters news agency this month, a small-scale study by Sinopharm researchers found that its efficacy against this variant was weaker than against the original virus.

Zimbabwe is expected to receive another 600,000 doses in March.

The BBC's Shingai Nyoka in Harare says coronavirus cases are on the decline, but Zimbabwe's 4% fatality rate has the authorities worried.

Since the pandemic began, Zimbabwe has recorded more than 35,000 coronavirus cases, including 1,410 deaths.

South Africa, meanwhile, is offering all of its doses of the Oxford-AstraZeneca vaccine to the African Union for distribution elsewhere on the continent, after a small-scale study suggested it had limited efficacy against the variant in the country.

Health Minister, Zweli Mkhize said it was "disappointing" but added South Africa was "determined not to be derailed from our commitment to roll out vaccines in February".

South Africa has now secured a total of nine million doses of Johnson & Johnson's yet-to-be-approved vaccine, with a first consignment expected this week.